Oxford Cancer Biomarkers (OCB) Ltd

www.oxfordcancerbiomarkers.com

Oxford Cancer Biomarkers is a personalised cancer medicines company developing predictive companion biomarker diagnostics to guide the identification and selection of cancer patients that respond favourably to emergent cancer drugs.

The company’s objective is to develop a suite of drug-specific companion diagnostic kits using its predictive biomarker technologies. The kits allows the biomarker to be directly measured in tumour biopsies or patient DNA and thereby patients that respond favourably to the drug identified.